Yu and colleagues identified a novel biomarker termed Unrecognized Hyperglycemia Risk (UHR) that improves early diabetes detection. This biomarker, emerging from National Health and Nutrition Examination Survey data, offers healthcare providers a more sensitive tool to identify individuals at risk, enabling timely interventions and potentially curbing the progression of type 2 diabetes globally.